Hepatitis induced by Kava (Piper methysticum rhizoma).

[1]  E. Ernst.  Safety concerns about kava , 2002, The Lancet.

[2]  A. Duchini.  Autoimmune hepatitis and interferon beta-1a for multiple sclerosis , 2002, American Journal of Gastroenterology.

[3]  L. Bertilsson,et al.  Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. , 2002, British journal of clinical pharmacology.

[4]  M. Kraft,et al.  [Fulminant liver failure after administration of the herbal antidepressant Kava-Kava]. , 2001, Deutsche medizinische Wochenschrift.

[5]  E. Walters,et al.  Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States , 2001, Annals of Internal Medicine.

[6]  W. Janssen,et al.  Smoking and Abnormalities in Renal Function , 2001 .

[7]  J. Desmeules,et al.  Hepatitis associated with Kava, a herbal remedy for anxiety , 2001, BMJ : British Medical Journal.

[8]  M. Rawlins,et al.  Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. , 2000, Journal of hepatology.

[9]  F. Stickel,et al.  The efficacy and safety of comfrey , 2000, Public Health Nutrition.

[10]  S. Shapiro,et al.  Epidemiological assessment of drug-induced disease , 2000, The Lancet.

[11]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[12]  F. Stickel,et al.  Hepatotoxicity of botanicals† , 2000, Public Health Nutrition.

[13]  E. Ernst,et al.  Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. , 2000, Journal of clinical psychopharmacology.

[14]  D. Schuppan,et al.  Acute hepatitis induced by greater celandine (Chelidonium majus). , 1999, Gastroenterology.

[15]  D. Schuppan,et al.  Herbal products for liver diseases: A therapeutic challenge for the new millennium , 1999, Hepatology.

[16]  L. Love,et al.  Chaparral-associated hepatotoxicity. , 1997, Archives of internal medicine.

[17]  C. McLean,et al.  Chinese herbal medicine, fulminant hepatitis, and liver transplantation. , 1996, The American journal of gastroenterology.

[18]  S. Jain,et al.  Hepatitis induced by traditional Chinese herbs; possible toxic components. , 1995, Gut.

[19]  C. Hiemke,et al.  Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain , 1994, Psychopharmacology.

[20]  D. Pessayre,et al.  Hepatotoxicity of germander in mice. , 1994, Gastroenterology.

[21]  T. Vial,et al.  Clinical Toxicity of the Interferons , 1994, Drug safety.

[22]  D. Jamieson,et al.  Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. , 1992, Pharmacology & toxicology.

[23]  D. Larrey,et al.  Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity , 1992, Annals of Internal Medicine.

[24]  S. Sherlock,et al.  Impaired oxidation of debrisoquine in patients with perhexiline liver injury. , 1984, Gut.

[25]  B. Steinhoff,et al.  Kava-kava: a lesson for the phytomedicine community. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[26]  H. Volz,et al.  Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial. , 1997, Pharmacopsychiatry.

[27]  E. Becker,et al.  The lymphocyte transformation test--a debated method for the evaluation of drug allergic hepatic injury. , 1995, Journal of hepatology.